AFP and hepatocellular carcinoma: To detect the targeting of 131I-antiAFPMcAb-GCV-BSA-NPs to hepatoma, we compared the uptake and the retention of 131I-antiAFPMcAb-GCV-BSA-NPs in AFP-positive HepG2 cells with those in AFP-negative HEK293 cells in vitro.